v3.24.3
Stockholders' Equity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 49 Months Ended
Nov. 02, 2023
Aug. 31, 2023
Sep. 30, 2023
Sep. 30, 2024
Aug. 31, 2020
Class Of Stock [Line Items]          
Maximum amount of sale covered in shelf registration statement         $ 300.0
Bile Acid Portfolio Acquisition          
Class Of Stock [Line Items]          
Shares issued, public offering price per share (in dollars per share)   $ 26.25      
Net proceeds from transaction   $ 202.2      
Private Placement | Bile Acid Portfolio Acquisition          
Class Of Stock [Line Items]          
Number of shares issued (in shares)   8,000,000      
Sales Agreement          
Class Of Stock [Line Items]          
Net proceeds from transaction $ 200.0        
Percentage of gross proceeds 3.00%        
Common Stock | Private Placement          
Class Of Stock [Line Items]          
Number of shares issued (in shares)     8,000,000    
Common Stock | Sales Agreement          
Class Of Stock [Line Items]          
Number of shares issued (in shares)       2,125,090  
Gross proceeds from issuance of common stock       $ 43.7  
Leerink Partners LLC          
Class Of Stock [Line Items]          
Maximum amount of offering issuance and sale covered in sales agreement         $ 75.0